Literature DB >> 2072452

Mutational definition of the human immunodeficiency virus type 1 Rev activation domain.

M H Malim1, D F McCarn, L S Tiley, B R Cullen.   

Abstract

Replication of human immunodeficiency virus type 1 requires the functional expression of the virally encoded Rev protein. The binding of this nuclear trans activator to its viral target sequence, the Rev-response element, induces the cytoplasmic expression of unspliced viral mRNAs. Mutation of the activation domain of Rev generates inactive proteins with normal RNA binding capabilities that inhibit wild-type Rev function in a trans-dominant manner. Here, we report that the activation domain comprises a minimum of nine amino acids, four of which are critically spaced leucines. The preservation of this essential sequence in other primate and nonprimate lentivirus Rev proteins indicates that this leucine-rich motif has been highly conserved during evolution. This conclusion, taken together with the observed permissiveness of a variety of eukaryotic cell types for Rev function, suggests that the target for the activation domain of Rev is likely to be a highly conserved cellular protein(s) intrinsic to nuclear mRNA transport or splicing.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2072452      PMCID: PMC248862          DOI: 10.1128/JVI.65.8.4248-4254.1991

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency.

Authors:  M H Malim; B R Cullen
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

2.  Conserved functional organization of the human immunodeficiency virus type 1 and visna virus Rev proteins.

Authors:  L S Tiley; M H Malim; B R Cullen
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus.

Authors:  P Sonigo; M Alizon; K Staskus; D Klatzmann; S Cole; O Danos; E Retzel; P Tiollais; A Haase; S Wain-Hobson
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism.

Authors:  B R Cullen
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

6.  High level transient expression of a chloramphenicol acetyl transferase gene by DEAE-dextran mediated DNA transfection coupled with a dimethyl sulfoxide or glycerol shock treatment.

Authors:  M A Lopata; D W Cleveland; B Sollner-Webb
Journal:  Nucleic Acids Res       Date:  1984-07-25       Impact factor: 16.971

7.  Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum.

Authors:  N Takahashi; Y Takahashi; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

8.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

9.  DNA sequence and characterization of the S. cerevisiae gene encoding adenylate cyclase.

Authors:  T Kataoka; D Broek; M Wigler
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

10.  Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products.

Authors:  E D Garrett; L S Tiley; B R Cullen
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more
  129 in total

1.  Polyvalent Rev decoys act as artificial Rev-responsive elements.

Authors:  T L Symensma; S Baskerville; A Yan; A D Ellington
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Using viral species specificity to define a critical protein/RNA interaction surface.

Authors:  G A Coburn; H L Wiegand; Y Kang; D N Ho; M M Georgiadis; B R Cullen
Journal:  Genes Dev       Date:  2001-05-15       Impact factor: 11.361

3.  The human Tap protein is a nuclear mRNA export factor that contains novel RNA-binding and nucleocytoplasmic transport sequences.

Authors:  Y Kang; B R Cullen
Journal:  Genes Dev       Date:  1999-05-01       Impact factor: 11.361

4.  Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells.

Authors:  P D Bieniasz; B R Cullen
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

5.  Identification of novel Saccharomyces cerevisiae proteins with nuclear export activity: cell cycle-regulated transcription factor ace2p shows cell cycle-independent nucleocytoplasmic shuttling.

Authors:  T H Jensen; M Neville; J C Rain; T McCarthy; P Legrain; M Rosbash
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

Review 6.  Mechanism of action of regulatory proteins encoded by complex retroviruses.

Authors:  B R Cullen
Journal:  Microbiol Rev       Date:  1992-09

7.  The NS2 proteins of parvovirus minute virus of mice are required for efficient nuclear egress of progeny virions in mouse cells.

Authors:  Virginie Eichwald; Laurent Daeffler; Michèle Klein; Jean Rommelaere; Nathalie Salomé
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA.

Authors:  S Venkatesan; S M Gerstberger; H Park; S M Holland; Y Nam
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

9.  Structural and functional analysis of the visna virus Rev-response element.

Authors:  L S Tiley; B R Cullen
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

10.  trans-dominant inhibition of human immunodeficiency virus type 1 Rev occurs through formation of inactive protein complexes.

Authors:  T J Hope; N P Klein; M E Elder; T G Parslow
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.